• Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

  • Jul 26 2024
  • Duración: 39 m
  • Podcast

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma Por arte de portada

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • touchPANEL DISCUSSION for touchHAEMATOLOGY

    Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.

    The experts

    • Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
    • Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
    • Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.

    This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

    For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
    Más Menos
activate_primeday_promo_in_buybox_DT
Ciencia
Más Menos

Lo que los oyentes dicen sobre Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles